SOM Biotech SL   Report issue

For profit Phase 2
Founded: Barcelona Spain (2009)

Organization Overview

First Clinical Trial
2014
NCT02191826
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

SOM Biotech SL